Search Results - "Veerman, G M"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Clinical implications of nintedanib pharmacokinetics in patients with pulmonary fibrosis by Agema, B.C., Berrich, M., Seuren, L., Sassen, S.D.T., Miedema, J.R., Koch, B.C.P., Wijsenbeek, M.S., Koolen, S.L.W., Mathijssen, R.H.J., Veerman, G.D.M.

    Published in Biomedicine & pharmacotherapy (01-10-2024)
    “…Nintedanib is used to treat both idiopathic and progressive pulmonary fibrosis (IPF/PPF). Evidence of both an exposure-response relationship and an…”
    Get full text
    Journal Article
  2. 2

    Rapid confirmatory identification of Mycobacterium bovis using a dot blotting immunodetection technique by Veerman, G M, Kelman, R, Colley, J, Pike, J G

    Published in Veterinary microbiology (01-05-1990)
    “…A safe, cost effective and accurate immunodetection technique for the rapid identification of Mycobacterium bovis colonies is described. One hundred and…”
    Get more information
    Journal Article
  3. 3
  4. 4

    1540PInfluence of cow’s milk on the absorption and exposure of erlotinib in NSCLC patients by Veerman, G D M, Hussaarts, K G A M, Peric, R, Oomen-de Hoop, E, Landa, K, Van Der Leest, C H, Broerse, S D, Rutten, H B, Paats, M S, van Gelder, T, Koolen, S L, Aerts, J G, van Leeuwen, R W, Mathijssen, R H

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background Erlotinib is an oral EGFR tyrosine kinase inhibitor used in NSCLC. Drug absorption depends largely on its solubility in the stomach and…”
    Get full text
    Journal Article
  5. 5

    Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib by Brouns, Anita J.W. M., van Veelen, Ard, Veerman, G. D. Marijn, Steendam, Christi, Dursun, Safiye, van der Leest, Cor, Croes, Sander, Dingemans, Anne-Marie C., Hendriks, Lizza E.L.

    Published in JTO clinical and research reports (01-05-2023)
    “…Bone metastases are frequent in patients with EGFR-mutated (EGFR+) NSCLC. Skeletal-related events (SREs) are common in these patients; however, no data on SRE…”
    Get full text
    Journal Article
  6. 6

    Operative Treatment of Acute Complications of Diverticular Disease: Primary or Secondary Anastomosis after Sigmoid Resection by A. W. Gooszen, H. G. Gooszen, W. Veerman, V. M. Van Dongen, J. Hermans, E. Klein Kranenbarg, R. A. E. M. Tollenaar

    Published in The European journal of surgery (01-01-2001)
    “…Objective: To assess the comparative effects of two surgical regimens on the outcome of acute complicated diverticular disease. Design: Retrospective study…”
    Get full text
    Journal Article